c type lips meaning Personality Test: The shape of your will give an insight into your personality traits Different Types Of Lip Shapes

2019;98:e15441

it's about feeling it too

herb oil Substances 0.000 description 1 239000001683 mentha spicata herb oil Substances 0.000 description 1 SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1 229960002248 meradimate Drugs 0.000 description 1 230000004060 metabolic process Effects 0.000 description 1 239000002207 metabolite Substances 0.000 description 1 PICNSXCJRMYANX-UHFFFAOYSA-N methyl 2-chloro-4-nitrobenzoate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)C=C1Cl PICNSXCJRMYANX-UHFFFAOYSA-N 0.000 description 1 HRGPYCVTDOECMG-RHBQXOTJSA-N methyl cedryl ether Chemical compound C1[C@@]23[C@H](C)CC[C@H]2C(C)(C)[C@]1([H])[C@@](OC)(C)CC3 HRGPYCVTDOECMG-RHBQXOTJSA-N 0.000 description 1 KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 description 1 239000010445 mica Substances 0.000 description 1 229910052618 mica group Inorganic materials 0.000 description 1 239000004200 microcrystalline wax Substances 0.000 description 1 235000019808 microcrystalline wax Nutrition 0.000 description 1 239000002480 mineral oil Substances 0.000 description 1 235000010446 mineral oil Nutrition 0.000 description 1 239000003607 modifier Substances 0.000 description 1 230000001333 moisturizer Effects 0.000 description 1 125000002950 monocyclic group Chemical group 0.000 description 1 WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1 SYRKOPHMPLPLPQ-UHFFFAOYSA-N n-[2-(4-oxo-3,1-benzoxazin-2-yl)phenyl]naphthalene-2-sulfonamide Chemical compound C1=CC=CC2=CC(S(=O)(=O)NC3=CC=CC=C3C=3OC(C4=CC=CC=C4N=3)=O)=CC=C21 SYRKOPHMPLPLPQ-UHFFFAOYSA-N 0.000 description 1 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1 125000005487 naphthalate group Chemical group 0.000 description 1 RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 1 JMXROTHPANUTOJ-UHFFFAOYSA-H naphthol green b Chemical compound [Na+].[Na+].[Na+].[Fe+3].C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21.C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21.C1=C(S([O-])(=O)=O)C=CC2=C(N=O)C([O-])=CC=C21 JMXROTHPANUTOJ-UHFFFAOYSA-H 0.000 description 1 229930014626 natural product Natural products 0.000 description 1 229940055311 natural red 26 Drugs 0.000 description 1 HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1 201000008051 neuronal ceroid lipofuscinosis Diseases 0.000 description 1 230000007935 neutral effect Effects 0.000 description 1 229910052757 nitrogen Inorganic materials 0.000 description 1 231100000344 non-irritating Toxicity 0.000 description 1 BOPPSUHPZARXTH-UHFFFAOYSA-N ocean propanal Chemical compound O=CC(C)CC1=CC=C2OCOC2=C1 BOPPSUHPZARXTH-UHFFFAOYSA-N 0.000 description 1 150000007823 ocimene derivatives Chemical class 0.000 description 1 CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1 IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1 229940048862 octyldodecyl neopentanoate Drugs 0.000 description 1 239000002674 ointment Substances 0.000 description 1 239000004006 olive oil Substances 0.000 description 1 235000008390 olive oil Nutrition 0.000 description 1 239000003605 opacifier Substances 0.000 description 1 239000001053 orange pigment Substances 0.000 description 1 125000005375 organosiloxane group Chemical group 0.000 description 1 239000007800 oxidant agent Substances 0.000 description 1 230000001590 oxidative effect Effects 0.000 description 1 BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1 SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1 238000004806 packaging method and process Methods 0.000 description 1 239000003346 palm kernel oil Substances 0.000 description 1 235000019865 palm kernel oil Nutrition 0.000 description 1 239000012188 paraffin wax Substances 0.000 description 1 235000012736 patent blue V Nutrition 0.000 description 1 230000037361 pathway Effects 0.000 description 1 235000020232 peanut Nutrition 0.000 description 1 235000019477 peppermint oil Nutrition 0.000 description 1 230000035699 permeability Effects 0.000 description 1 229940127557 pharmaceutical product Drugs 0.000 description 1 JDQVBGQWADMTAM-UHFFFAOYSA-N phenethyl isobutyrate Chemical compound CC(C)C(=O)OCCC1=CC=CC=C1 JDQVBGQWADMTAM-UHFFFAOYSA-N 0.000 description 1 229940031826 phenolate Drugs 0.000 description 1 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1 229940057874 phenyl trimethicone Drugs 0.000 description 1 238000007539 photo-oxidation reaction Methods 0.000 description 1 230000008832 photodamage Effects 0.000 description 1 239000003504 photosensitizing agent Substances 0.000 description 1 231100000760 phototoxic Toxicity 0.000 description 1 208000007578 phototoxic dermatitis Diseases 0.000 description 1 108010072011 phycocyanobilin Proteins 0.000 description 1 MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1 235000019175 phylloquinone Nutrition 0.000 description 1 239000011772 phylloquinone Substances 0.000 description 1 SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1 229960001898 phytomenadione Drugs 0.000 description 1 IUGYQRQAERSCNH-UHFFFAOYSA-M pivalate Chemical compound CC(C)(C)C([O-])=O IUGYQRQAERSCNH-UHFFFAOYSA-M 0.000 description 1 239000000419 plant extract Substances 0.000 description 1 229920001515 polyalkylene glycol Polymers 0.000 description 1 229920000647 polyepoxide Polymers 0.000 description 1 238000006116 polymerization reaction Methods 0.000 description 1 229920005862 polyol Polymers 0.000 description 1 229920000098 polyolefin Polymers 0.000 description 1 150000008442 polyphenolic compounds Chemical class 0.000 description 1 229920001451 polypropylene glycol Polymers 0.000 description 1 229940100498 polysilicone-15 Drugs 0.000 description 1 229920002282 polysilicones-15 Polymers 0.000 description 1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1 239000003755 preservative agent Substances 0.000 description 1 230000002265 prevention Effects 0.000 description 1 235000019260 propionic acid Nutrition 0.000 description 1 239000011814 protection agent Substances 0.000 description 1 150000003212 purines Chemical class 0.000 description 1 KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1 229960003581 pyridoxal Drugs 0.000 description 1 235000008164 pyridoxal Nutrition 0.000 description 1 239000011674 pyridoxal Substances 0.000 description 1 235000008151 pyridoxamine Nutrition 0.000 description 1 239000011699 pyridoxamine Substances 0.000 description 1 235000008160 pyridoxine Nutrition 0.000 description 1 239000011677 pyridoxine Substances 0.000 description 1 239000013635 pyrimidine dimer Substances 0.000 description 1 229910052903 pyrophyllite Inorganic materials 0.000 description 1 239000010453 quartz Substances 0.000 description 1 230000000171 quenching effect Effects 0.000 description 1 IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1 239000003642 reactive oxygen metabolite Substances 0.000 description 1 230000009467 reduction Effects 0.000 description 1 230000007261 regionalization Effects 0.000 description 1 230000003014 reinforcing effect Effects 0.000 description 1 230000033458 reproduction Effects 0.000 description 1 238000011160 research Methods 0.000 description 1 230000027756 respiratory electron transport chain Effects 0.000 description 1 230000002207 retinal effect Effects 0.000 description 1 150000004508 retinoic acid derivatives Chemical class 0.000 description 1 150000004492 retinoid derivatives Chemical class 0.000 description 1 229960000342 retinol acetate Drugs 0.000 description 1 235000019173 retinyl acetate Nutrition 0.000 description 1 239000011770 retinyl acetate Substances 0.000 description 1 QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1 238000012552 review Methods 0.000 description 1 229960002477 riboflavin Drugs 0.000 description 1 239000004170 rice bran wax Substances 0.000 description 1 235000019384 rice bran wax Nutrition 0.000 description 1 IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1 235000013974 saffron Nutrition 0.000 description 1 239000004248 saffron Substances 0.000 description 1 229960001860 salicylate Drugs 0.000 description 1 229940096995 sclareolide Drugs 0.000 description 1 238000010517 secondary reaction Methods 0.000 description 1 230000035945 sensitivity Effects 0.000 description 1 230000001235 sensitizing effect Effects 0.000 description 1 238000000926 separation method Methods 0.000 description 1 230000009919 sequestration Effects 0.000 description 1 229910052709 silver Inorganic materials 0.000 description 1 239000004332 silver Substances 0.000 description 1 229930000308 sinensal Natural products 0.000 description 1 230000009759 skin aging Effects 0.000 description 1 230000008591 skin barrier function Effects 0.000 description 1 230000037380 skin damage Effects 0.000 description 1 239000000779 smoke Substances 0.000 description 1 239000000344 soap Substances 0.000 description 1 229910052708 sodium Inorganic materials 0.000 description 1 239000011734 sodium Substances 0.000 description 1 UWMZZSRDUVJJDP-UHFFFAOYSA-M sodium 2-[3-(2-methylanilino)-6-(2-methyl-4-sulfonatoanilino)xanthen-10-ium-9-yl]benzoate Chemical compound [Na+].Cc1ccccc1Nc1ccc2c(-c3ccccc3C([O-])=O)c3ccc(Nc4ccc(cc4C)S([O-])(=O)=O)cc3[o+]c2c1 UWMZZSRDUVJJDP-UHFFFAOYSA-M 0.000 description 1 COEZWFYORILMOM-UHFFFAOYSA-M sodium 4-[(2,4-dihydroxyphenyl)diazenyl]benzenesulfonate Chemical compound [Na+].OC1=CC(O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 COEZWFYORILMOM-UHFFFAOYSA-M 0.000 description 1 239000001632 sodium acetate Substances 0.000 description 1 235000017281 sodium acetate Nutrition 0.000 description 1 DJDYMAHXZBQZKH-UHFFFAOYSA-M sodium;1-amino-4-(cyclohexylamino)-9,10-dioxoanthracene-2-sulfonate Chemical compound [Na+].C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S([O-])(=O)=O)C=C1NC1CCCCC1 DJDYMAHXZBQZKH-UHFFFAOYSA-M 0.000 description 1 NOJQBSUJVLPAQO-UHFFFAOYSA-L sodium;zinc;hexadecyl phosphate Chemical compound [Na+].[Zn+2].CCCCCCCCCCCCCCCCOP([O-])([O-])=O NOJQBSUJVLPAQO-UHFFFAOYSA-L 0.000 description 1 238000000638 solvent extraction Methods 0.000 description 1 LJFWQNJLLOFIJK-UHFFFAOYSA-N solvent violet 13 Chemical compound C1=CC(C)=CC=C1NC1=CC=C(O)C2=C1C(=O)C1=CC=CC=C1C2=O LJFWQNJLLOFIJK-UHFFFAOYSA-N 0.000 description 1 239000003549 soybean oil Substances 0.000 description 1 235000012424 soybean oil Nutrition 0.000 description 1 235000019721 spearmint oil Nutrition 0.000 description 1 238000013112 stability test Methods 0.000 description 1 238000004659 sterilization and disinfection Methods 0.000 description 1 150000003440 styrenes Chemical class 0.000 description 1 238000006467 substitution reaction Methods 0.000 description 1 KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1 XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 description 1 229910052717 sulfur Inorganic materials 0.000 description 1 239000011593 sulfur Substances 0.000 description 1 CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1 229960000368 sulisobenzone Drugs 0.000 description 1 230000008833 sun damage Effects 0.000 description 1 239000004094 surface-active agent Substances 0.000 description 1 239000000725 suspension Substances 0.000 description 1 230000002195 synergetic effect Effects 0.000 description 1 239000003760 tallow Substances 0.000 description 1 239000001648 tannin Substances 0.000 description 1 235000018553 tannin Nutrition 0.000 description 1 229920001864 tannin Polymers 0.000 description 1 235000013616 tea Nutrition 0.000 description 1 208000009056 telangiectasis Diseases 0.000 description 1 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1 TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1 230000001225 therapeutic effect Effects 0.000 description 1 238000002560 therapeutic procedure Methods 0.000 description 1 235000019157 thiamine Nutrition 0.000 description 1 KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1 239000011721 thiamine Substances 0.000 description 1 239000001585 thymus vulgaris Substances 0.000 description 1 231100000331 toxic Toxicity 0.000 description 1 230000002588 toxic effect Effects 0.000 description 1 231100000419 toxicity Toxicity 0.000 description 1 230000001988 toxicity Effects 0.000 description 1 MBDOYVRWFFCFHM-UHFFFAOYSA-N trans-2-hexenal Natural products CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 1 XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1 VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1 230000009466 transformation Effects 0.000 description 1 238000000844 transformation Methods 0.000 description 1 229910001428 transition metal ion Inorganic materials 0.000 description 1 HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1 LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1 ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1 UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1 229940030300 trolamine salicylate Drugs 0.000 description 1 229960004441 tyrosine Drugs 0.000 description 1 235000013799 ultramarine blue Nutrition 0.000 description 1 229940099259 vaseline Drugs 0.000 description 1 235000019245 violaxanthin Nutrition 0.000 description 1 SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C( C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1 235000019156 vitamin B Nutrition 0.000 description 1 239000011720 vitamin B Substances 0.000 description 1 235000019163 vitamin B12 Nutrition 0.000 description 1 239000011715 vitamin B12 Substances 0.000 description 1 235000019158 vitamin B6 Nutrition 0.000 description 1 239000011726 vitamin B6 Substances 0.000 description 1 235000019166 vitamin D Nutrition 0.000 description 1 239000011710 vitamin D Substances 0.000 description 1 150000003710 vitamin D derivatives Chemical class 0.000 description 1 239000011712 vitamin K Substances 0.000 description 1 235000019168 vitamin K Nutrition 0.000 description 1 229940046008 vitamin d Drugs 0.000 description 1 239000008170 walnut oil Substances 0.000 description 1 238000004078 waterproofing Methods 0.000 description 1 235000019386 wax ester Nutrition 0.000 description 1 238000005303 weighing Methods 0.000 description 1 229940118846 witch hazel Drugs 0.000 description 1 PEAGNRWWSMMRPZ-UHFFFAOYSA-L woodstain scarlet Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 PEAGNRWWSMMRPZ-UHFFFAOYSA-L 0.000 description 1 239000000230 xanthan gum Substances 0.000 description 1 229920001285 xanthan gum Polymers 0.000 description 1 229940082509 xanthan gum Drugs 0.000 description 1 235000010493 xanthan gum Nutrition 0.000 description 1 FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1 235000008210 xanthophylls Nutrition 0.000 description 1 235000010930 zeaxanthin Nutrition 0.000 description 1 239000001775 zeaxanthin Substances 0.000 description 1 229940043269 zeaxanthin Drugs 0.000 description 1 XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1 Classifications CCHEMISTRY

Forensic sleep medicine: nocturnal wandering and violence

tdTomato indicates the enkephalinergic iSPNs, EGFP indicates shRNA transduced cells, and the cyan channel shows the GSTO2 immunostaining

148 VargheseJ.JamesJ